PL359847A1 - Kompozycja w postaci cząstek, zawierająca eletryptan, o kontrolowanym uwalnianiu według profilu sigmoidalnego - Google Patents

Kompozycja w postaci cząstek, zawierająca eletryptan, o kontrolowanym uwalnianiu według profilu sigmoidalnego

Info

Publication number
PL359847A1
PL359847A1 PL35984701A PL35984701A PL359847A1 PL 359847 A1 PL359847 A1 PL 359847A1 PL 35984701 A PL35984701 A PL 35984701A PL 35984701 A PL35984701 A PL 35984701A PL 359847 A1 PL359847 A1 PL 359847A1
Authority
PL
Poland
Prior art keywords
composition containing
controlled release
particulate composition
release according
containing eletriptan
Prior art date
Application number
PL35984701A
Other languages
English (en)
Inventor
Raspide Manaud Pierre Frederic De
Ross James Macrae
Mathias Walther
Original Assignee
Pfizer, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Inc. filed Critical Pfizer, Inc.
Publication of PL359847A1 publication Critical patent/PL359847A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
PL35984701A 2000-08-02 2001-07-18 Kompozycja w postaci cząstek, zawierająca eletryptan, o kontrolowanym uwalnianiu według profilu sigmoidalnego PL359847A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0018968.8A GB0018968D0 (en) 2000-08-02 2000-08-02 Particulate composition
PCT/IB2001/001279 WO2002009675A1 (en) 2000-08-02 2001-07-18 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release

Publications (1)

Publication Number Publication Date
PL359847A1 true PL359847A1 (pl) 2004-09-06

Family

ID=9896843

Family Applications (1)

Application Number Title Priority Date Filing Date
PL35984701A PL359847A1 (pl) 2000-08-02 2001-07-18 Kompozycja w postaci cząstek, zawierająca eletryptan, o kontrolowanym uwalnianiu według profilu sigmoidalnego

Country Status (39)

Country Link
US (1) US20020034545A1 (pl)
EP (1) EP1365748B1 (pl)
JP (1) JP2004505034A (pl)
KR (1) KR20030024820A (pl)
CN (1) CN1630511A (pl)
AP (1) AP2001002233A0 (pl)
AR (1) AR030099A1 (pl)
AT (1) ATE308978T1 (pl)
AU (1) AU2001270932A1 (pl)
BG (1) BG107361A (pl)
BR (1) BR0112839A (pl)
CA (1) CA2417887C (pl)
CZ (1) CZ2003241A3 (pl)
DE (1) DE60114887T2 (pl)
EA (1) EA200300110A1 (pl)
EC (1) ECSP034451A (pl)
EE (1) EE200300051A (pl)
ES (1) ES2250429T3 (pl)
GB (1) GB0018968D0 (pl)
GT (1) GT200100149A (pl)
HR (1) HRP20030036A2 (pl)
HU (1) HUP0301453A2 (pl)
IL (1) IL153494A0 (pl)
IS (1) IS6649A (pl)
MA (1) MA26934A1 (pl)
MX (1) MXPA03000999A (pl)
NO (1) NO20030498D0 (pl)
NZ (1) NZ522976A (pl)
OA (1) OA12348A (pl)
PA (1) PA8523101A1 (pl)
PE (1) PE20020385A1 (pl)
PL (1) PL359847A1 (pl)
PY (1) PY0117547A (pl)
SK (1) SK1082003A3 (pl)
SV (1) SV2002000574A (pl)
TN (1) TNSN01115A1 (pl)
UY (1) UY26861A1 (pl)
WO (1) WO2002009675A1 (pl)
ZA (1) ZA200300868B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
US20060134012A1 (en) * 2002-12-16 2006-06-22 Symington John M Temporary pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing
BRPI0409127A (pt) * 2003-04-11 2006-03-28 Pfizer combinação farmacêutica compreendendo eletriptano e bicarbonato de sódio
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
WO2005120456A2 (en) * 2004-06-09 2005-12-22 Pfizer Limited Formulation of eletriptan
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
CA2596548A1 (en) * 2005-01-31 2006-08-03 Kyorin Pharmaceutical Co., Ltd. Multiple unit oral sustained release preparation and process for production of the same
DK1915137T3 (da) 2005-08-10 2013-11-04 Add Advanced Drug Delivery Technologies Ltd Oralt præparat med kontrolleret frisætning
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
ATE496623T1 (de) 2006-04-26 2011-02-15 Supernus Pharmaceuticals Inc Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil
WO2008115797A1 (en) * 2007-03-16 2008-09-25 Pavo, Inc. Therapeutic compositions and methods
BRPI0814363A2 (pt) 2007-07-25 2015-01-27 Biolex Therapeutics Inc Produtos fármacos de interferon de liberação controlada e tratamento de infecção por hcv usando os mesmos
KR20120110098A (ko) 2009-11-16 2012-10-09 에보니크 룀 게엠베하 고형 (메트)아크릴레이트 공중합체를 분산제에 의해 분산된 형태로 전환시키는 방법
KR20170054446A (ko) * 2014-09-09 2017-05-17 찰스톤 래보라토리즈, 인크. 약학적 조성물
GB201716716D0 (en) * 2017-10-12 2017-11-29 Univ Of Hertfordshire Higher Education Corporation Method for coating particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release

Also Published As

Publication number Publication date
TNSN01115A1 (fr) 2005-11-10
DE60114887T2 (de) 2006-07-20
UY26861A1 (es) 2002-02-28
GB0018968D0 (en) 2000-09-20
MA26934A1 (fr) 2004-12-20
MXPA03000999A (es) 2003-06-09
ECSP034451A (es) 2003-03-10
NZ522976A (en) 2004-11-26
HUP0301453A2 (hu) 2003-08-28
IL153494A0 (en) 2003-07-06
ZA200300868B (en) 2004-04-16
PA8523101A1 (es) 2002-08-26
EE200300051A (et) 2004-10-15
BR0112839A (pt) 2003-06-24
AU2001270932A1 (en) 2002-02-13
NO20030498L (no) 2003-01-31
AR030099A1 (es) 2003-08-13
US20020034545A1 (en) 2002-03-21
SV2002000574A (es) 2002-12-02
PY0117547A (es) 2003-11-03
ES2250429T3 (es) 2006-04-16
BG107361A (bg) 2003-06-30
ATE308978T1 (de) 2005-11-15
NO20030498D0 (no) 2003-01-31
CZ2003241A3 (cs) 2004-02-18
WO2002009675A1 (en) 2002-02-07
HRP20030036A2 (en) 2003-04-30
AP2001002233A0 (en) 2001-09-30
IS6649A (is) 2002-12-05
CA2417887A1 (en) 2002-02-07
SK1082003A3 (en) 2004-09-08
DE60114887D1 (de) 2005-12-15
OA12348A (en) 2004-03-19
EA200300110A1 (ru) 2003-06-26
EP1365748B1 (en) 2005-11-09
JP2004505034A (ja) 2004-02-19
CN1630511A (zh) 2005-06-22
CA2417887C (en) 2006-11-14
PE20020385A1 (es) 2002-05-11
EP1365748A2 (en) 2003-12-03
KR20030024820A (ko) 2003-03-26
GT200100149A (es) 2002-06-25
WO2002009675A9 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
DK1553929T3 (da) Sammensætning med kontrolleret frigivelse.
EE200100293A (et) Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II
IS2932B (is) Fúlvestrant samsetning
BR0214972B1 (pt) artigo absorvente.
BR0105361B1 (pt) artigo absorvente.
BR0100865B8 (pt) artigo absorvente.
BR0103836B1 (pt) artigo absorvente.
DE60043447D1 (de) Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid
BR0100151B1 (pt) artigo absorvente.
ID26774A (id) Senyawa benzimidazol, pembuatan dan penggunaannya sebagai komposisi farmasi
DE60103582D1 (de) Zusammensetzungen mit kontrollierter Freisetzung
PL359847A1 (pl) Kompozycja w postaci cząstek, zawierająca eletryptan, o kontrolowanym uwalnianiu według profilu sigmoidalnego
BR0100961B1 (pt) artigo absorvente.
FI20001153L (fi) Virtausta edistävä koostumus
BR0102028B1 (pt) artigo absorvente.
DE60103187D1 (de) Sicherungsmutter
DE60116858D1 (de) Zusammensetzung
DE60041783D1 (de) Bremseinheit
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
BR0212092B1 (pt) artigo absorvente.
BR0107047B1 (pt) artigo absorvente.
EP1307662A4 (en) Brake plate
DE60200104D1 (de) Desodorierende Zusammensetzung
ITTO20020744A1 (it) Composizione.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)